Literature DB >> 22694761

Comparison of adherence to chlamydia screening guidelines among Title X providers and non-Title X providers in the California Family Planning, Access, Care, and Treatment Program.

Joan M Chow1, Heike Thiel de Bocanegra, Denis Hulett, Hye-Youn Park, Philip Darney.   

Abstract

BACKGROUND: Annual chlamydia screening is recommended for adolescent and young adult females and targeted screening is recommended for women ≥26 years based on risk. Although screening levels have increased over time, adherence to these guidelines varies, with high levels of adherence among Title X family planning providers. However, previous studies of provider variation in screening rates have not adjusted for differences in clinic and client population characteristics.
METHODS: Administrative claims from the California Family Planning, Access, Care, and Treatment (Family PACT) program were used to (1) examine clinic and client sociodemographic characteristics by provider group-Title X-funded public sector, non-Title X public sector, and private sector providers, and (2) estimate age-specific screening and differences in rates by provider group during 2009.
RESULTS: Among 833 providers, Title X providers were more likely than non-Title X public sector providers and private sector providers to serve a higher client volume, a higher proportion of clients aged ≤25 years, and a higher proportion of African American clients. Non-Title X public providers were more likely to be located in rural areas, compared with Title X grantees and private sector providers. Title X providers had the largest absolute difference in screening rates for young females vs. older females (10.9%). Unadjusted screening rates for young clients were lower among non-Title X public sector providers (54%) compared with private sector and Title X providers (64% each). After controlling for provider group, urban location, client volume, and percent African American, private sector providers had higher screening rates than Title X and non-Title X public providers.
CONCLUSIONS: Screening rates for females were higher among private providers compared with Title X and non-Title X public providers. However, only Title X providers were more likely to adhere to screening guidelines through high screening rates for young females and low screening rates for older females.

Entities:  

Mesh:

Year:  2012        PMID: 22694761      PMCID: PMC3411333          DOI: 10.1089/jwh.2011.3376

Source DB:  PubMed          Journal:  J Womens Health (Larchmt)        ISSN: 1540-9996            Impact factor:   2.681


  13 in total

Review 1.  Uses and abuses of screening tests.

Authors:  David A Grimes; Kenneth F Schulz
Journal:  Lancet       Date:  2002-03-09       Impact factor: 79.321

2.  Reduction in unnecessary Chlamydia screening among older women at title X-funded family planning sites following a structural intervention--San Francisco, 2009.

Authors:  Kyle T Bernstein; Julia L Marcus; Ameera Snell; Sally Liska; Leah Rauch; Susan S Philip
Journal:  Sex Transm Dis       Date:  2011-02       Impact factor: 2.830

3.  Missed opportunities for chlamydia screening of young women in the United States.

Authors:  Karen Hoover; Guoyu Tao
Journal:  Obstet Gynecol       Date:  2008-05       Impact factor: 7.661

4.  Sexually transmitted infection testing and screening in hospital-based primary care visits by women.

Authors:  Jill S Huppert; Elizabeth Goodman; Jane Khoury; Gail Slap
Journal:  Obstet Gynecol       Date:  2005-02       Impact factor: 7.661

5.  Infrequency of sexually transmitted disease screening among sexually experienced U.S. female adolescents.

Authors:  Lynne C Fiscus; Carol A Ford; William C Miller
Journal:  Perspect Sex Reprod Health       Date:  2004 Nov-Dec

6.  Estimating Chlamydia screening rates by using reported sexually transmitted disease tests for sexually active women aged 16 to 25 years in the United States.

Authors:  Guoyu Tao; Lin H Tian; Thomas A Peterman
Journal:  Sex Transm Dis       Date:  2007-03       Impact factor: 2.830

7.  Screening for chlamydial infection: U.S. Preventive Services Task Force recommendation statement.

Authors: 
Journal:  Ann Intern Med       Date:  2007-06-18       Impact factor: 25.391

8.  Low rates of both asymptomatic chlamydia screening and diagnostic testing of women in US outpatient clinics.

Authors:  Karen Hoover; Guoyu Tao; Charlotte Kent
Journal:  Obstet Gynecol       Date:  2008-10       Impact factor: 7.661

9.  Chlamydia screening among sexually active young female enrollees of health plans--United States, 2000-2007.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2009-04-17       Impact factor: 17.586

Review 10.  Efficacy of interventions to increase the uptake of chlamydia screening in primary care: a systematic review.

Authors:  Rebecca J Guy; Hammad Ali; Bette Liu; Simone Poznanski; James Ward; Basil Donovan; John Kaldor; Jane Hocking
Journal:  BMC Infect Dis       Date:  2011-08-05       Impact factor: 3.090

View more
  2 in total

1.  Missed Opportunities for Chlamydia Screening in Title X Family Planning Clinics.

Authors:  Sarah Goldenkranz Salomon; Elizabeth Torrone; Wendy Nakatsukasa-Ono; David N Fine
Journal:  Sex Transm Dis       Date:  2017-09       Impact factor: 2.830

2.  Trends in Cervical Cancer Screening in California's Family Planning Program.

Authors:  Heike Thiel de Bocanegra; Sandy K Navarro; Narissa J Nonzee; Sitaram Vangala; Xinkai Zhou; Charlene Chang; Anna-Barbara Moscicki
Journal:  J Low Genit Tract Dis       Date:  2018-07       Impact factor: 1.925

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.